These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

264 related items for PubMed ID: 18533606

  • 1.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 2. [Insulin therapy in type 2 diabetes].
    Hummel M.
    MMW Fortschr Med; 2011 Jun 09; 153(23):56-9, 61; quiz 62. PubMed ID: 21688497
    [No Abstract] [Full Text] [Related]

  • 3. [When tablets are no longer enough. Which insulin for type 2 diabetic patients?].
    MMW Fortschr Med; 2002 Sep 19; 144(38):58. PubMed ID: 12395711
    [No Abstract] [Full Text] [Related]

  • 4. [A simple regimen only lasts a short time].
    Einecke D.
    MMW Fortschr Med; 2007 Oct 04; 149(40):12-4. PubMed ID: 18018501
    [No Abstract] [Full Text] [Related]

  • 5.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 6. HbA(1c) targets for type 2 diabetes: how many, …how far!
    Giugliano D, Ceriello A, Esposito K.
    Diabetes Res Clin Pract; 2012 Jun 04; 96(3):414-5. PubMed ID: 21963106
    [No Abstract] [Full Text] [Related]

  • 7.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 8.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 9.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 10. Starting insulin therapy in type 2 diabetes: lesson 1.
    McCall AL.
    Curr Diab Rep; 2005 Oct 04; 5(5):325-6. PubMed ID: 16188164
    [No Abstract] [Full Text] [Related]

  • 11. [Insulin therapy in type II diabetes].
    Beyer J, Küstner E.
    Wien Med Wochenschr; 1997 Oct 04; 147(9):211-6. PubMed ID: 9281234
    [Abstract] [Full Text] [Related]

  • 12. Summaries for patients. A comparison of three insulin regimens (morning glargine, bedtime glargine, or bedtime neutral protamine Hagedorn) in addition to a pill for treating type 2 diabetes.
    Ann Intern Med; 2003 Jun 17; 138(12):I33. PubMed ID: 12809480
    [No Abstract] [Full Text] [Related]

  • 13. [Long-acting insulins in the treatment of type 2 diabetes: a hard choice].
    Liebl A.
    MMW Fortschr Med; 2015 Apr 16; 157(7):65-8. PubMed ID: 26012462
    [No Abstract] [Full Text] [Related]

  • 14. [Researchers illuminate diabetes therapy].
    Pflege Z; 2014 Feb 16; 67(2):126. PubMed ID: 24730335
    [No Abstract] [Full Text] [Related]

  • 15. As U-500 Insulin Safety Concerns Mount, It's Time to Rethink Safe Use of Strengths Above U-100.
    Shastay A.
    Home Healthc Now; 2015 Oct 16; 33(9):501-2. PubMed ID: 26418111
    [No Abstract] [Full Text] [Related]

  • 16. [Oral antidiabetic agents--2. Individualized stepwise therapy].
    Bachmann W.
    MMW Fortschr Med; 2000 Mar 09; 142(10):36-8. PubMed ID: 10748602
    [No Abstract] [Full Text] [Related]

  • 17. [National practice guideline for diabetes. Managing your diabetic patient properly].
    Stiefelhagen P.
    MMW Fortschr Med; 2002 Jul 11; 144(27-28):4-8, 10. PubMed ID: 12198877
    [No Abstract] [Full Text] [Related]

  • 18. Summaries for patients. Comparison of two types of insulin added to diabetes pills in poorly controlled type 2 diabetes.
    Ann Intern Med; 2008 Oct 21; 149(8):I-46. PubMed ID: 18936498
    [No Abstract] [Full Text] [Related]

  • 19. [The new oral antidiabetics. Type 2 diabetes under control only with tablets?].
    Hanefeld M.
    MMW Fortschr Med; 2001 May 24; 143(21):38-42. PubMed ID: 11420830
    [Abstract] [Full Text] [Related]

  • 20. Summaries for patients: Does adding exenatide to insulin treatment benefit patients with type 2 diabetes?
    Ann Intern Med; 2011 Jan 18; 154(2):I-40. PubMed ID: 21135289
    [No Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 14.